Description

According to our latest research, the global Recombinant DNA Drug market size will reach USD 318207 million in 2031, growing at a CAGR of 8.3% over the analysis period.

Recombinant DNA drugs are therapeutic agents produced using recombinant DNA technology, which involves inserting a gene encoding a therapeutic protein into a host cell (such as bacteria, yeast, or mammalian cells) to enable large-scale production of that protein. These drugs are typically biologics that mimic or supplement the function of naturally occurring substances in the body.

This report is a detailed and comprehensive analysis for global Recombinant DNA Drug market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:
Global Recombinant DNA Drug market size and forecasts, in consumption value ($ Million), 2020-2031
Global Recombinant DNA Drug market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Recombinant DNA Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Recombinant DNA Drug market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Recombinant DNA Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Recombinant DNA Drug market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novo Nordisk, Amgen, Eli Lilly, Sanofi, Bayer, Bristol-Myers Squibb, GlaxoSmithKline, AbbVie, Sandoz, Biogen, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation
Recombinant DNA Drug market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Fusion Protein
    Recombinant Growth Factor
    Recombinant Hormone
    Recombinant Interferon
    Recombinant Interleukin
    Recombinant Coagulation Factor
    Other

Market segment by Application
    Cancers
    Autoimmune Diseases
    Metabolic Disorders
    Infectious Diseases

Market segment by players, this report covers
    Novo Nordisk
    Amgen
    Eli Lilly
    Sanofi
    Bayer
    Bristol-Myers Squibb
    GlaxoSmithKline
    AbbVie
    Sandoz
    Biogen
    Pfizer
    GenSci
    3SBIO
    Organon Pharma
    Roche
    Swedish Orphan Biovitrum
    CSPC
    Johnson & Johnson
    Merck
    Takeda

Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Recombinant DNA Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Recombinant DNA Drug, with revenue, gross margin, and global market share of Recombinant DNA Drug from 2020 to 2025.
Chapter 3, the Recombinant DNA Drug competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Recombinant DNA Drug market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Recombinant DNA Drug.
Chapter 13, to describe Recombinant DNA Drug research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Recombinant DNA Drug by Type
        1.3.1 Overview: Global Recombinant DNA Drug Market Size by Type: 2020 Versus 2024 Versus 2031
        1.3.2 Global Recombinant DNA Drug Consumption Value Market Share by Type in 2024
        1.3.3 Fusion Protein
        1.3.4 Recombinant Growth Factor
        1.3.5 Recombinant Hormone
        1.3.6 Recombinant Interferon
        1.3.7 Recombinant Interleukin
        1.3.8 Recombinant Coagulation Factor
        1.3.9 Other
    1.4 Global Recombinant DNA Drug Market by Application
        1.4.1 Overview: Global Recombinant DNA Drug Market Size by Application: 2020 Versus 2024 Versus 2031
        1.4.2 Cancers
        1.4.3 Autoimmune Diseases
        1.4.4 Metabolic Disorders
        1.4.5 Infectious Diseases
    1.5 Global Recombinant DNA Drug Market Size & Forecast
    1.6 Global Recombinant DNA Drug Market Size and Forecast by Region
        1.6.1 Global Recombinant DNA Drug Market Size by Region: 2020 VS 2024 VS 2031
        1.6.2 Global Recombinant DNA Drug Market Size by Region, (2020-2031)
        1.6.3 North America Recombinant DNA Drug Market Size and Prospect (2020-2031)
        1.6.4 Europe Recombinant DNA Drug Market Size and Prospect (2020-2031)
        1.6.5 Asia-Pacific Recombinant DNA Drug Market Size and Prospect (2020-2031)
        1.6.6 South America Recombinant DNA Drug Market Size and Prospect (2020-2031)
        1.6.7 Middle East & Africa Recombinant DNA Drug Market Size and Prospect (2020-2031)

2 Company Profiles
    2.1 Novo Nordisk
        2.1.1 Novo Nordisk Details
        2.1.2 Novo Nordisk Major Business
        2.1.3 Novo Nordisk Recombinant DNA Drug Product and Solutions
        2.1.4 Novo Nordisk Recombinant DNA Drug Revenue, Gross Margin and Market Share (2020-2025)
        2.1.5 Novo Nordisk Recent Developments and Future Plans
    2.2 Amgen
        2.2.1 Amgen Details
        2.2.2 Amgen Major Business
        2.2.3 Amgen Recombinant DNA Drug Product and Solutions
        2.2.4 Amgen Recombinant DNA Drug Revenue, Gross Margin and Market Share (2020-2025)
        2.2.5 Amgen Recent Developments and Future Plans
    2.3 Eli Lilly
        2.3.1 Eli Lilly Details
        2.3.2 Eli Lilly Major Business
        2.3.3 Eli Lilly Recombinant DNA Drug Product and Solutions
        2.3.4 Eli Lilly Recombinant DNA Drug Revenue, Gross Margin and Market Share (2020-2025)
        2.3.5 Eli Lilly Recent Developments and Future Plans
    2.4 Sanofi
        2.4.1 Sanofi Details
        2.4.2 Sanofi Major Business
        2.4.3 Sanofi Recombinant DNA Drug Product and Solutions
        2.4.4 Sanofi Recombinant DNA Drug Revenue, Gross Margin and Market Share (2020-2025)
        2.4.5 Sanofi Recent Developments and Future Plans
    2.5 Bayer
        2.5.1 Bayer Details
        2.5.2 Bayer Major Business
        2.5.3 Bayer Recombinant DNA Drug Product and Solutions
        2.5.4 Bayer Recombinant DNA Drug Revenue, Gross Margin and Market Share (2020-2025)
        2.5.5 Bayer Recent Developments and Future Plans
    2.6 Bristol-Myers Squibb
        2.6.1 Bristol-Myers Squibb Details
        2.6.2 Bristol-Myers Squibb Major Business
        2.6.3 Bristol-Myers Squibb Recombinant DNA Drug Product and Solutions
        2.6.4 Bristol-Myers Squibb Recombinant DNA Drug Revenue, Gross Margin and Market Share (2020-2025)
        2.6.5 Bristol-Myers Squibb Recent Developments and Future Plans
    2.7 GlaxoSmithKline
        2.7.1 GlaxoSmithKline Details
        2.7.2 GlaxoSmithKline Major Business
        2.7.3 GlaxoSmithKline Recombinant DNA Drug Product and Solutions
        2.7.4 GlaxoSmithKline Recombinant DNA Drug Revenue, Gross Margin and Market Share (2020-2025)
        2.7.5 GlaxoSmithKline Recent Developments and Future Plans
    2.8 AbbVie
        2.8.1 AbbVie Details
        2.8.2 AbbVie Major Business
        2.8.3 AbbVie Recombinant DNA Drug Product and Solutions
        2.8.4 AbbVie Recombinant DNA Drug Revenue, Gross Margin and Market Share (2020-2025)
        2.8.5 AbbVie Recent Developments and Future Plans
    2.9 Sandoz
        2.9.1 Sandoz Details
        2.9.2 Sandoz Major Business
        2.9.3 Sandoz Recombinant DNA Drug Product and Solutions
        2.9.4 Sandoz Recombinant DNA Drug Revenue, Gross Margin and Market Share (2020-2025)
        2.9.5 Sandoz Recent Developments and Future Plans
    2.10 Biogen
        2.10.1 Biogen Details
        2.10.2 Biogen Major Business
        2.10.3 Biogen Recombinant DNA Drug Product and Solutions
        2.10.4 Biogen Recombinant DNA Drug Revenue, Gross Margin and Market Share (2020-2025)
        2.10.5 Biogen Recent Developments and Future Plans
    2.11 Pfizer
        2.11.1 Pfizer Details
        2.11.2 Pfizer Major Business
        2.11.3 Pfizer Recombinant DNA Drug Product and Solutions
        2.11.4 Pfizer Recombinant DNA Drug Revenue, Gross Margin and Market Share (2020-2025)
        2.11.5 Pfizer Recent Developments and Future Plans
    2.12 GenSci
        2.12.1 GenSci Details
        2.12.2 GenSci Major Business
        2.12.3 GenSci Recombinant DNA Drug Product and Solutions
        2.12.4 GenSci Recombinant DNA Drug Revenue, Gross Margin and Market Share (2020-2025)
        2.12.5 GenSci Recent Developments and Future Plans
    2.13 3SBIO
        2.13.1 3SBIO Details
        2.13.2 3SBIO Major Business
        2.13.3 3SBIO Recombinant DNA Drug Product and Solutions
        2.13.4 3SBIO Recombinant DNA Drug Revenue, Gross Margin and Market Share (2020-2025)
        2.13.5 3SBIO Recent Developments and Future Plans
    2.14 Organon Pharma
        2.14.1 Organon Pharma Details
        2.14.2 Organon Pharma Major Business
        2.14.3 Organon Pharma Recombinant DNA Drug Product and Solutions
        2.14.4 Organon Pharma Recombinant DNA Drug Revenue, Gross Margin and Market Share (2020-2025)
        2.14.5 Organon Pharma Recent Developments and Future Plans
    2.15 Roche
        2.15.1 Roche Details
        2.15.2 Roche Major Business
        2.15.3 Roche Recombinant DNA Drug Product and Solutions
        2.15.4 Roche Recombinant DNA Drug Revenue, Gross Margin and Market Share (2020-2025)
        2.15.5 Roche Recent Developments and Future Plans
    2.16 Swedish Orphan Biovitrum
        2.16.1 Swedish Orphan Biovitrum Details
        2.16.2 Swedish Orphan Biovitrum Major Business
        2.16.3 Swedish Orphan Biovitrum Recombinant DNA Drug Product and Solutions
        2.16.4 Swedish Orphan Biovitrum Recombinant DNA Drug Revenue, Gross Margin and Market Share (2020-2025)
        2.16.5 Swedish Orphan Biovitrum Recent Developments and Future Plans
    2.17 CSPC
        2.17.1 CSPC Details
        2.17.2 CSPC Major Business
        2.17.3 CSPC Recombinant DNA Drug Product and Solutions
        2.17.4 CSPC Recombinant DNA Drug Revenue, Gross Margin and Market Share (2020-2025)
        2.17.5 CSPC Recent Developments and Future Plans
    2.18 Johnson & Johnson
        2.18.1 Johnson & Johnson Details
        2.18.2 Johnson & Johnson Major Business
        2.18.3 Johnson & Johnson Recombinant DNA Drug Product and Solutions
        2.18.4 Johnson & Johnson Recombinant DNA Drug Revenue, Gross Margin and Market Share (2020-2025)
        2.18.5 Johnson & Johnson Recent Developments and Future Plans
    2.19 Merck
        2.19.1 Merck Details
        2.19.2 Merck Major Business
        2.19.3 Merck Recombinant DNA Drug Product and Solutions
        2.19.4 Merck Recombinant DNA Drug Revenue, Gross Margin and Market Share (2020-2025)
        2.19.5 Merck Recent Developments and Future Plans
    2.20 Takeda
        2.20.1 Takeda Details
        2.20.2 Takeda Major Business
        2.20.3 Takeda Recombinant DNA Drug Product and Solutions
        2.20.4 Takeda Recombinant DNA Drug Revenue, Gross Margin and Market Share (2020-2025)
        2.20.5 Takeda Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Recombinant DNA Drug Revenue and Share by Players (2020-2025)
    3.2 Market Share Analysis (2024)
        3.2.1 Market Share of Recombinant DNA Drug by Company Revenue
        3.2.2 Top 3 Recombinant DNA Drug Players Market Share in 2024
        3.2.3 Top 6 Recombinant DNA Drug Players Market Share in 2024
    3.3 Recombinant DNA Drug Market: Overall Company Footprint Analysis
        3.3.1 Recombinant DNA Drug Market: Region Footprint
        3.3.2 Recombinant DNA Drug Market: Company Product Type Footprint
        3.3.3 Recombinant DNA Drug Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Recombinant DNA Drug Consumption Value and Market Share by Type (2020-2025)
    4.2 Global Recombinant DNA Drug Market Forecast by Type (2026-2031)

5 Market Size Segment by Application
    5.1 Global Recombinant DNA Drug Consumption Value Market Share by Application (2020-2025)
    5.2 Global Recombinant DNA Drug Market Forecast by Application (2026-2031)

6 North America
    6.1 North America Recombinant DNA Drug Consumption Value by Type (2020-2031)
    6.2 North America Recombinant DNA Drug Market Size by Application (2020-2031)
    6.3 North America Recombinant DNA Drug Market Size by Country
        6.3.1 North America Recombinant DNA Drug Consumption Value by Country (2020-2031)
        6.3.2 United States Recombinant DNA Drug Market Size and Forecast (2020-2031)
        6.3.3 Canada Recombinant DNA Drug Market Size and Forecast (2020-2031)
        6.3.4 Mexico Recombinant DNA Drug Market Size and Forecast (2020-2031)

7 Europe
    7.1 Europe Recombinant DNA Drug Consumption Value by Type (2020-2031)
    7.2 Europe Recombinant DNA Drug Consumption Value by Application (2020-2031)
    7.3 Europe Recombinant DNA Drug Market Size by Country
        7.3.1 Europe Recombinant DNA Drug Consumption Value by Country (2020-2031)
        7.3.2 Germany Recombinant DNA Drug Market Size and Forecast (2020-2031)
        7.3.3 France Recombinant DNA Drug Market Size and Forecast (2020-2031)
        7.3.4 United Kingdom Recombinant DNA Drug Market Size and Forecast (2020-2031)
        7.3.5 Russia Recombinant DNA Drug Market Size and Forecast (2020-2031)
        7.3.6 Italy Recombinant DNA Drug Market Size and Forecast (2020-2031)

8 Asia-Pacific
    8.1 Asia-Pacific Recombinant DNA Drug Consumption Value by Type (2020-2031)
    8.2 Asia-Pacific Recombinant DNA Drug Consumption Value by Application (2020-2031)
    8.3 Asia-Pacific Recombinant DNA Drug Market Size by Region
        8.3.1 Asia-Pacific Recombinant DNA Drug Consumption Value by Region (2020-2031)
        8.3.2 China Recombinant DNA Drug Market Size and Forecast (2020-2031)
        8.3.3 Japan Recombinant DNA Drug Market Size and Forecast (2020-2031)
        8.3.4 South Korea Recombinant DNA Drug Market Size and Forecast (2020-2031)
        8.3.5 India Recombinant DNA Drug Market Size and Forecast (2020-2031)
        8.3.6 Southeast Asia Recombinant DNA Drug Market Size and Forecast (2020-2031)
        8.3.7 Australia Recombinant DNA Drug Market Size and Forecast (2020-2031)

9 South America
    9.1 South America Recombinant DNA Drug Consumption Value by Type (2020-2031)
    9.2 South America Recombinant DNA Drug Consumption Value by Application (2020-2031)
    9.3 South America Recombinant DNA Drug Market Size by Country
        9.3.1 South America Recombinant DNA Drug Consumption Value by Country (2020-2031)
        9.3.2 Brazil Recombinant DNA Drug Market Size and Forecast (2020-2031)
        9.3.3 Argentina Recombinant DNA Drug Market Size and Forecast (2020-2031)

10 Middle East & Africa
    10.1 Middle East & Africa Recombinant DNA Drug Consumption Value by Type (2020-2031)
    10.2 Middle East & Africa Recombinant DNA Drug Consumption Value by Application (2020-2031)
    10.3 Middle East & Africa Recombinant DNA Drug Market Size by Country
        10.3.1 Middle East & Africa Recombinant DNA Drug Consumption Value by Country (2020-2031)
        10.3.2 Turkey Recombinant DNA Drug Market Size and Forecast (2020-2031)
        10.3.3 Saudi Arabia Recombinant DNA Drug Market Size and Forecast (2020-2031)
        10.3.4 UAE Recombinant DNA Drug Market Size and Forecast (2020-2031)

11 Market Dynamics
    11.1 Recombinant DNA Drug Market Drivers
    11.2 Recombinant DNA Drug Market Restraints
    11.3 Recombinant DNA Drug Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Recombinant DNA Drug Industry Chain
    12.2 Recombinant DNA Drug Upstream Analysis
    12.3 Recombinant DNA Drug Midstream Analysis
    12.4 Recombinant DNA Drug Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Recombinant DNA Drug Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
 Table 2. Global Recombinant DNA Drug Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
 Table 3. Global Recombinant DNA Drug Consumption Value by Region (2020-2025) & (USD Million)
 Table 4. Global Recombinant DNA Drug Consumption Value by Region (2026-2031) & (USD Million)
 Table 5. Novo Nordisk Company Information, Head Office, and Major Competitors
 Table 6. Novo Nordisk Major Business
 Table 7. Novo Nordisk Recombinant DNA Drug Product and Solutions
 Table 8. Novo Nordisk Recombinant DNA Drug Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 9. Novo Nordisk Recent Developments and Future Plans
 Table 10. Amgen Company Information, Head Office, and Major Competitors
 Table 11. Amgen Major Business
 Table 12. Amgen Recombinant DNA Drug Product and Solutions
 Table 13. Amgen Recombinant DNA Drug Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 14. Amgen Recent Developments and Future Plans
 Table 15. Eli Lilly Company Information, Head Office, and Major Competitors
 Table 16. Eli Lilly Major Business
 Table 17. Eli Lilly Recombinant DNA Drug Product and Solutions
 Table 18. Eli Lilly Recombinant DNA Drug Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 19. Sanofi Company Information, Head Office, and Major Competitors
 Table 20. Sanofi Major Business
 Table 21. Sanofi Recombinant DNA Drug Product and Solutions
 Table 22. Sanofi Recombinant DNA Drug Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 23. Sanofi Recent Developments and Future Plans
 Table 24. Bayer Company Information, Head Office, and Major Competitors
 Table 25. Bayer Major Business
 Table 26. Bayer Recombinant DNA Drug Product and Solutions
 Table 27. Bayer Recombinant DNA Drug Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 28. Bayer Recent Developments and Future Plans
 Table 29. Bristol-Myers Squibb Company Information, Head Office, and Major Competitors
 Table 30. Bristol-Myers Squibb Major Business
 Table 31. Bristol-Myers Squibb Recombinant DNA Drug Product and Solutions
 Table 32. Bristol-Myers Squibb Recombinant DNA Drug Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 33. Bristol-Myers Squibb Recent Developments and Future Plans
 Table 34. GlaxoSmithKline Company Information, Head Office, and Major Competitors
 Table 35. GlaxoSmithKline Major Business
 Table 36. GlaxoSmithKline Recombinant DNA Drug Product and Solutions
 Table 37. GlaxoSmithKline Recombinant DNA Drug Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 38. GlaxoSmithKline Recent Developments and Future Plans
 Table 39. AbbVie Company Information, Head Office, and Major Competitors
 Table 40. AbbVie Major Business
 Table 41. AbbVie Recombinant DNA Drug Product and Solutions
 Table 42. AbbVie Recombinant DNA Drug Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 43. AbbVie Recent Developments and Future Plans
 Table 44. Sandoz Company Information, Head Office, and Major Competitors
 Table 45. Sandoz Major Business
 Table 46. Sandoz Recombinant DNA Drug Product and Solutions
 Table 47. Sandoz Recombinant DNA Drug Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 48. Sandoz Recent Developments and Future Plans
 Table 49. Biogen Company Information, Head Office, and Major Competitors
 Table 50. Biogen Major Business
 Table 51. Biogen Recombinant DNA Drug Product and Solutions
 Table 52. Biogen Recombinant DNA Drug Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 53. Biogen Recent Developments and Future Plans
 Table 54. Pfizer Company Information, Head Office, and Major Competitors
 Table 55. Pfizer Major Business
 Table 56. Pfizer Recombinant DNA Drug Product and Solutions
 Table 57. Pfizer Recombinant DNA Drug Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 58. Pfizer Recent Developments and Future Plans
 Table 59. GenSci Company Information, Head Office, and Major Competitors
 Table 60. GenSci Major Business
 Table 61. GenSci Recombinant DNA Drug Product and Solutions
 Table 62. GenSci Recombinant DNA Drug Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 63. GenSci Recent Developments and Future Plans
 Table 64. 3SBIO Company Information, Head Office, and Major Competitors
 Table 65. 3SBIO Major Business
 Table 66. 3SBIO Recombinant DNA Drug Product and Solutions
 Table 67. 3SBIO Recombinant DNA Drug Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 68. 3SBIO Recent Developments and Future Plans
 Table 69. Organon Pharma Company Information, Head Office, and Major Competitors
 Table 70. Organon Pharma Major Business
 Table 71. Organon Pharma Recombinant DNA Drug Product and Solutions
 Table 72. Organon Pharma Recombinant DNA Drug Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 73. Organon Pharma Recent Developments and Future Plans
 Table 74. Roche Company Information, Head Office, and Major Competitors
 Table 75. Roche Major Business
 Table 76. Roche Recombinant DNA Drug Product and Solutions
 Table 77. Roche Recombinant DNA Drug Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 78. Roche Recent Developments and Future Plans
 Table 79. Swedish Orphan Biovitrum Company Information, Head Office, and Major Competitors
 Table 80. Swedish Orphan Biovitrum Major Business
 Table 81. Swedish Orphan Biovitrum Recombinant DNA Drug Product and Solutions
 Table 82. Swedish Orphan Biovitrum Recombinant DNA Drug Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 83. Swedish Orphan Biovitrum Recent Developments and Future Plans
 Table 84. CSPC Company Information, Head Office, and Major Competitors
 Table 85. CSPC Major Business
 Table 86. CSPC Recombinant DNA Drug Product and Solutions
 Table 87. CSPC Recombinant DNA Drug Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 88. CSPC Recent Developments and Future Plans
 Table 89. Johnson & Johnson Company Information, Head Office, and Major Competitors
 Table 90. Johnson & Johnson Major Business
 Table 91. Johnson & Johnson Recombinant DNA Drug Product and Solutions
 Table 92. Johnson & Johnson Recombinant DNA Drug Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 93. Johnson & Johnson Recent Developments and Future Plans
 Table 94. Merck Company Information, Head Office, and Major Competitors
 Table 95. Merck Major Business
 Table 96. Merck Recombinant DNA Drug Product and Solutions
 Table 97. Merck Recombinant DNA Drug Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 98. Merck Recent Developments and Future Plans
 Table 99. Takeda Company Information, Head Office, and Major Competitors
 Table 100. Takeda Major Business
 Table 101. Takeda Recombinant DNA Drug Product and Solutions
 Table 102. Takeda Recombinant DNA Drug Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 103. Takeda Recent Developments and Future Plans
 Table 104. Global Recombinant DNA Drug Revenue (USD Million) by Players (2020-2025)
 Table 105. Global Recombinant DNA Drug Revenue Share by Players (2020-2025)
 Table 106. Breakdown of Recombinant DNA Drug by Company Type (Tier 1, Tier 2, and Tier 3)
 Table 107. Market Position of Players in Recombinant DNA Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
 Table 108. Head Office of Key Recombinant DNA Drug Players
 Table 109. Recombinant DNA Drug Market: Company Product Type Footprint
 Table 110. Recombinant DNA Drug Market: Company Product Application Footprint
 Table 111. Recombinant DNA Drug New Market Entrants and Barriers to Market Entry
 Table 112. Recombinant DNA Drug Mergers, Acquisition, Agreements, and Collaborations
 Table 113. Global Recombinant DNA Drug Consumption Value (USD Million) by Type (2020-2025)
 Table 114. Global Recombinant DNA Drug Consumption Value Share by Type (2020-2025)
 Table 115. Global Recombinant DNA Drug Consumption Value Forecast by Type (2026-2031)
 Table 116. Global Recombinant DNA Drug Consumption Value by Application (2020-2025)
 Table 117. Global Recombinant DNA Drug Consumption Value Forecast by Application (2026-2031)
 Table 118. North America Recombinant DNA Drug Consumption Value by Type (2020-2025) & (USD Million)
 Table 119. North America Recombinant DNA Drug Consumption Value by Type (2026-2031) & (USD Million)
 Table 120. North America Recombinant DNA Drug Consumption Value by Application (2020-2025) & (USD Million)
 Table 121. North America Recombinant DNA Drug Consumption Value by Application (2026-2031) & (USD Million)
 Table 122. North America Recombinant DNA Drug Consumption Value by Country (2020-2025) & (USD Million)
 Table 123. North America Recombinant DNA Drug Consumption Value by Country (2026-2031) & (USD Million)
 Table 124. Europe Recombinant DNA Drug Consumption Value by Type (2020-2025) & (USD Million)
 Table 125. Europe Recombinant DNA Drug Consumption Value by Type (2026-2031) & (USD Million)
 Table 126. Europe Recombinant DNA Drug Consumption Value by Application (2020-2025) & (USD Million)
 Table 127. Europe Recombinant DNA Drug Consumption Value by Application (2026-2031) & (USD Million)
 Table 128. Europe Recombinant DNA Drug Consumption Value by Country (2020-2025) & (USD Million)
 Table 129. Europe Recombinant DNA Drug Consumption Value by Country (2026-2031) & (USD Million)
 Table 130. Asia-Pacific Recombinant DNA Drug Consumption Value by Type (2020-2025) & (USD Million)
 Table 131. Asia-Pacific Recombinant DNA Drug Consumption Value by Type (2026-2031) & (USD Million)
 Table 132. Asia-Pacific Recombinant DNA Drug Consumption Value by Application (2020-2025) & (USD Million)
 Table 133. Asia-Pacific Recombinant DNA Drug Consumption Value by Application (2026-2031) & (USD Million)
 Table 134. Asia-Pacific Recombinant DNA Drug Consumption Value by Region (2020-2025) & (USD Million)
 Table 135. Asia-Pacific Recombinant DNA Drug Consumption Value by Region (2026-2031) & (USD Million)
 Table 136. South America Recombinant DNA Drug Consumption Value by Type (2020-2025) & (USD Million)
 Table 137. South America Recombinant DNA Drug Consumption Value by Type (2026-2031) & (USD Million)
 Table 138. South America Recombinant DNA Drug Consumption Value by Application (2020-2025) & (USD Million)
 Table 139. South America Recombinant DNA Drug Consumption Value by Application (2026-2031) & (USD Million)
 Table 140. South America Recombinant DNA Drug Consumption Value by Country (2020-2025) & (USD Million)
 Table 141. South America Recombinant DNA Drug Consumption Value by Country (2026-2031) & (USD Million)
 Table 142. Middle East & Africa Recombinant DNA Drug Consumption Value by Type (2020-2025) & (USD Million)
 Table 143. Middle East & Africa Recombinant DNA Drug Consumption Value by Type (2026-2031) & (USD Million)
 Table 144. Middle East & Africa Recombinant DNA Drug Consumption Value by Application (2020-2025) & (USD Million)
 Table 145. Middle East & Africa Recombinant DNA Drug Consumption Value by Application (2026-2031) & (USD Million)
 Table 146. Middle East & Africa Recombinant DNA Drug Consumption Value by Country (2020-2025) & (USD Million)
 Table 147. Middle East & Africa Recombinant DNA Drug Consumption Value by Country (2026-2031) & (USD Million)
 Table 148. Global Key Players of Recombinant DNA Drug Upstream (Raw Materials)
 Table 149. Global Recombinant DNA Drug Typical Customers


List of Figures
 Figure 1. Recombinant DNA Drug Picture
 Figure 2. Global Recombinant DNA Drug Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
 Figure 3. Global Recombinant DNA Drug Consumption Value Market Share by Type in 2024
 Figure 4. Fusion Protein
 Figure 5. Recombinant Growth Factor
 Figure 6. Recombinant Hormone
 Figure 7. Recombinant Interferon
 Figure 8. Recombinant Interleukin
 Figure 9. Recombinant Coagulation Factor
 Figure 10. Other
 Figure 11. Global Recombinant DNA Drug Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
 Figure 12. Recombinant DNA Drug Consumption Value Market Share by Application in 2024
 Figure 13. Cancers Picture
 Figure 14. Autoimmune Diseases Picture
 Figure 15. Metabolic Disorders Picture
 Figure 16. Infectious Diseases Picture
 Figure 17. Global Recombinant DNA Drug Consumption Value, (USD Million): 2020 & 2024 & 2031
 Figure 18. Global Recombinant DNA Drug Consumption Value and Forecast (2020-2031) & (USD Million)
 Figure 19. Global Market Recombinant DNA Drug Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
 Figure 20. Global Recombinant DNA Drug Consumption Value Market Share by Region (2020-2031)
 Figure 21. Global Recombinant DNA Drug Consumption Value Market Share by Region in 2024
 Figure 22. North America Recombinant DNA Drug Consumption Value (2020-2031) & (USD Million)
 Figure 23. Europe Recombinant DNA Drug Consumption Value (2020-2031) & (USD Million)
 Figure 24. Asia-Pacific Recombinant DNA Drug Consumption Value (2020-2031) & (USD Million)
 Figure 25. South America Recombinant DNA Drug Consumption Value (2020-2031) & (USD Million)
 Figure 26. Middle East & Africa Recombinant DNA Drug Consumption Value (2020-2031) & (USD Million)
 Figure 27. Company Three Recent Developments and Future Plans
 Figure 28. Global Recombinant DNA Drug Revenue Share by Players in 2024
 Figure 29. Recombinant DNA Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
 Figure 30. Market Share of Recombinant DNA Drug by Player Revenue in 2024
 Figure 31. Top 3 Recombinant DNA Drug Players Market Share in 2024
 Figure 32. Top 6 Recombinant DNA Drug Players Market Share in 2024
 Figure 33. Global Recombinant DNA Drug Consumption Value Share by Type (2020-2025)
 Figure 34. Global Recombinant DNA Drug Market Share Forecast by Type (2026-2031)
 Figure 35. Global Recombinant DNA Drug Consumption Value Share by Application (2020-2025)
 Figure 36. Global Recombinant DNA Drug Market Share Forecast by Application (2026-2031)
 Figure 37. North America Recombinant DNA Drug Consumption Value Market Share by Type (2020-2031)
 Figure 38. North America Recombinant DNA Drug Consumption Value Market Share by Application (2020-2031)
 Figure 39. North America Recombinant DNA Drug Consumption Value Market Share by Country (2020-2031)
 Figure 40. United States Recombinant DNA Drug Consumption Value (2020-2031) & (USD Million)
 Figure 41. Canada Recombinant DNA Drug Consumption Value (2020-2031) & (USD Million)
 Figure 42. Mexico Recombinant DNA Drug Consumption Value (2020-2031) & (USD Million)
 Figure 43. Europe Recombinant DNA Drug Consumption Value Market Share by Type (2020-2031)
 Figure 44. Europe Recombinant DNA Drug Consumption Value Market Share by Application (2020-2031)
 Figure 45. Europe Recombinant DNA Drug Consumption Value Market Share by Country (2020-2031)
 Figure 46. Germany Recombinant DNA Drug Consumption Value (2020-2031) & (USD Million)
 Figure 47. France Recombinant DNA Drug Consumption Value (2020-2031) & (USD Million)
 Figure 48. United Kingdom Recombinant DNA Drug Consumption Value (2020-2031) & (USD Million)
 Figure 49. Russia Recombinant DNA Drug Consumption Value (2020-2031) & (USD Million)
 Figure 50. Italy Recombinant DNA Drug Consumption Value (2020-2031) & (USD Million)
 Figure 51. Asia-Pacific Recombinant DNA Drug Consumption Value Market Share by Type (2020-2031)
 Figure 52. Asia-Pacific Recombinant DNA Drug Consumption Value Market Share by Application (2020-2031)
 Figure 53. Asia-Pacific Recombinant DNA Drug Consumption Value Market Share by Region (2020-2031)
 Figure 54. China Recombinant DNA Drug Consumption Value (2020-2031) & (USD Million)
 Figure 55. Japan Recombinant DNA Drug Consumption Value (2020-2031) & (USD Million)
 Figure 56. South Korea Recombinant DNA Drug Consumption Value (2020-2031) & (USD Million)
 Figure 57. India Recombinant DNA Drug Consumption Value (2020-2031) & (USD Million)
 Figure 58. Southeast Asia Recombinant DNA Drug Consumption Value (2020-2031) & (USD Million)
 Figure 59. Australia Recombinant DNA Drug Consumption Value (2020-2031) & (USD Million)
 Figure 60. South America Recombinant DNA Drug Consumption Value Market Share by Type (2020-2031)
 Figure 61. South America Recombinant DNA Drug Consumption Value Market Share by Application (2020-2031)
 Figure 62. South America Recombinant DNA Drug Consumption Value Market Share by Country (2020-2031)
 Figure 63. Brazil Recombinant DNA Drug Consumption Value (2020-2031) & (USD Million)
 Figure 64. Argentina Recombinant DNA Drug Consumption Value (2020-2031) & (USD Million)
 Figure 65. Middle East & Africa Recombinant DNA Drug Consumption Value Market Share by Type (2020-2031)
 Figure 66. Middle East & Africa Recombinant DNA Drug Consumption Value Market Share by Application (2020-2031)
 Figure 67. Middle East & Africa Recombinant DNA Drug Consumption Value Market Share by Country (2020-2031)
 Figure 68. Turkey Recombinant DNA Drug Consumption Value (2020-2031) & (USD Million)
 Figure 69. Saudi Arabia Recombinant DNA Drug Consumption Value (2020-2031) & (USD Million)
 Figure 70. UAE Recombinant DNA Drug Consumption Value (2020-2031) & (USD Million)
 Figure 71. Recombinant DNA Drug Market Drivers
 Figure 72. Recombinant DNA Drug Market Restraints
 Figure 73. Recombinant DNA Drug Market Trends
 Figure 74. Porters Five Forces Analysis
 Figure 75. Recombinant DNA Drug Industrial Chain
 Figure 76. Methodology
 Figure 77. Research Process and Data Source

Companies Mentioned

Novo Nordisk
Amgen
Eli Lilly
Sanofi
Bayer
Bristol-Myers Squibb
GlaxoSmithKline
AbbVie
Sandoz
Biogen
Pfizer
GenSci
3SBIO
Organon Pharma
Roche
Swedish Orphan Biovitrum
CSPC
Johnson & Johnson
Merck
Takeda